Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.70868712 |
2 | positive regulation by symbiont of host defense response (GO:0052509) | 5.51774459 |
3 | modulation by symbiont of host defense response (GO:0052031) | 5.51774459 |
4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.51774459 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.51774459 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.51774459 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.51774459 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.21088952 |
9 | negative regulation of interleukin-12 production (GO:0032695) | 5.00849765 |
10 | macrophage activation involved in immune response (GO:0002281) | 4.93621692 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.76850654 |
12 | detection of molecule of bacterial origin (GO:0032490) | 4.66082807 |
13 | response to peptidoglycan (GO:0032494) | 4.51777068 |
14 | microglial cell activation (GO:0001774) | 4.42624216 |
15 | respiratory burst (GO:0045730) | 4.24566936 |
16 | positive regulation of interferon-alpha production (GO:0032727) | 4.23728237 |
17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.18846649 |
18 | negative regulation of cell killing (GO:0031342) | 4.18846649 |
19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17588581 |
20 | immunoglobulin mediated immune response (GO:0016064) | 4.15090380 |
21 | detection of other organism (GO:0098543) | 4.14765028 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07118955 |
23 | neutrophil activation (GO:0042119) | 4.02839424 |
24 | regulation of interferon-alpha production (GO:0032647) | 3.98900440 |
25 | granulocyte activation (GO:0036230) | 3.88210145 |
26 | detection of external biotic stimulus (GO:0098581) | 3.87960125 |
27 | response to host immune response (GO:0052572) | 3.86231101 |
28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.86231101 |
29 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.73883085 |
30 | positive regulation of B cell differentiation (GO:0045579) | 3.72868838 |
31 | macrophage activation (GO:0042116) | 3.65759205 |
32 | myeloid cell activation involved in immune response (GO:0002275) | 3.65557072 |
33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60360711 |
34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.59325992 |
35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.58514500 |
36 | response to host (GO:0075136) | 3.58514500 |
37 | response to host defenses (GO:0052200) | 3.58514500 |
38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57415496 |
39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57415496 |
40 | response to muramyl dipeptide (GO:0032495) | 3.57113401 |
41 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.54194815 |
42 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.53633677 |
43 | detection of bacterium (GO:0016045) | 3.53054418 |
44 | detection of biotic stimulus (GO:0009595) | 3.52251998 |
45 | regulation of B cell differentiation (GO:0045577) | 3.51716334 |
46 | B cell receptor signaling pathway (GO:0050853) | 3.44713452 |
47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.42629820 |
48 | positive regulation of interferon-beta production (GO:0032728) | 3.38996909 |
49 | cellular extravasation (GO:0045123) | 3.36216525 |
50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35301930 |
51 | negative regulation of B cell proliferation (GO:0030889) | 3.35226133 |
52 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.33409743 |
53 | cellular response to zinc ion (GO:0071294) | 3.30846301 |
54 | regulation of gamma-delta T cell activation (GO:0046643) | 3.30260250 |
55 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.28667390 |
56 | negative regulation of interleukin-17 production (GO:0032700) | 3.27148704 |
57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.26513013 |
58 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.23437069 |
59 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.23042774 |
60 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.22847691 |
61 | neutrophil mediated immunity (GO:0002446) | 3.19321470 |
62 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.16809531 |
63 | natural killer cell mediated immunity (GO:0002228) | 3.16809531 |
64 | regulation of mast cell degranulation (GO:0043304) | 3.14845062 |
65 | myeloid leukocyte mediated immunity (GO:0002444) | 3.13438933 |
66 | response to protozoan (GO:0001562) | 3.13346903 |
67 | B cell mediated immunity (GO:0019724) | 3.12960019 |
68 | leukocyte aggregation (GO:0070486) | 3.12545440 |
69 | leukocyte mediated cytotoxicity (GO:0001909) | 3.11005406 |
70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10921005 |
71 | negative regulation of interleukin-1 production (GO:0032692) | 3.09783493 |
72 | regulation of antigen processing and presentation (GO:0002577) | 3.08515918 |
73 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07250241 |
74 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.07206404 |
75 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.06362838 |
76 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.05148796 |
77 | negative regulation of phagocytosis (GO:0050765) | 3.04300817 |
78 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.03772909 |
79 | germinal center formation (GO:0002467) | 3.02716921 |
80 | myeloid leukocyte activation (GO:0002274) | 3.01338308 |
81 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.98325426 |
82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98302763 |
83 | negative regulation of interleukin-6 production (GO:0032715) | 2.97971012 |
84 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.97426031 |
85 | regulation of mast cell activation (GO:0033003) | 2.96821974 |
86 | positive regulation of type 2 immune response (GO:0002830) | 2.95600649 |
87 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.93953472 |
88 | interferon-gamma production (GO:0032609) | 2.93452854 |
89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92683105 |
90 | positive regulation of interleukin-6 production (GO:0032755) | 2.92329970 |
91 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91979881 |
92 | regulation of interleukin-12 production (GO:0032655) | 2.91692787 |
93 | hepatocyte apoptotic process (GO:0097284) | 2.89273084 |
94 | positive regulation of mast cell activation (GO:0033005) | 2.88970629 |
95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88092520 |
96 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.87219307 |
97 | positive regulation of mast cell degranulation (GO:0043306) | 2.87219307 |
98 | T-helper 1 type immune response (GO:0042088) | 2.87212225 |
99 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.87158971 |
100 | regulation of interleukin-17 production (GO:0032660) | 2.86964849 |
101 | positive regulation of chemokine production (GO:0032722) | 2.85532024 |
102 | dendritic cell migration (GO:0036336) | 2.85358058 |
103 | pinocytosis (GO:0006907) | 2.83398433 |
104 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.82009138 |
105 | leukocyte degranulation (GO:0043299) | 2.81307591 |
106 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.80928999 |
107 | neutrophil chemotaxis (GO:0030593) | 2.80316300 |
108 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79774253 |
109 | regulation of interleukin-6 production (GO:0032675) | 2.78659399 |
110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.78053219 |
111 | regulation of interferon-beta production (GO:0032648) | 2.77610761 |
112 | regulation of RIG-I signaling pathway (GO:0039535) | 2.76836373 |
113 | tolerance induction (GO:0002507) | 2.74720357 |
114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.74270353 |
115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.73714700 |
116 | response to interleukin-15 (GO:0070672) | 2.73319065 |
117 | neutrophil migration (GO:1990266) | 2.72728524 |
118 | myeloid dendritic cell activation (GO:0001773) | 2.72303301 |
119 | B cell homeostasis (GO:0001782) | 2.71264151 |
120 | response to type I interferon (GO:0034340) | 2.70962037 |
121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69838928 |
122 | defense response to protozoan (GO:0042832) | 2.68646536 |
123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.68555511 |
124 | mast cell activation (GO:0045576) | 2.67037184 |
125 | cellular response to type I interferon (GO:0071357) | 2.66570128 |
126 | type I interferon signaling pathway (GO:0060337) | 2.66570128 |
127 | sequestering of metal ion (GO:0051238) | 2.65730199 |
128 | cellular response to interferon-beta (GO:0035458) | 2.65566740 |
129 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.63667829 |
130 | superoxide anion generation (GO:0042554) | 2.63010955 |
131 | positive regulation of macrophage differentiation (GO:0045651) | 2.62685534 |
132 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.62651119 |
133 | cytokine secretion (GO:0050663) | 2.62048303 |
134 | necroptotic process (GO:0070266) | 2.58671480 |
135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.57399838 |
136 | NIK/NF-kappaB signaling (GO:0038061) | 2.56377000 |
137 | lymphocyte mediated immunity (GO:0002449) | 2.55286356 |
138 | regulation of leukocyte degranulation (GO:0043300) | 2.54983722 |
139 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.53818571 |
140 | oligosaccharide catabolic process (GO:0009313) | 2.53682610 |
141 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.53335192 |
142 | regulation of necroptotic process (GO:0060544) | 2.53125144 |
143 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.52410354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.76844876 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.46448452 |
3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.25731886 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12941653 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.99139325 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.96943282 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.83878220 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.66858628 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.43548410 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41547270 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08320692 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03201757 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02278923 |
14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.97948447 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96823448 |
16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.89098471 |
17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77298131 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.65842501 |
19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.62463780 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.53282074 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.52003009 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40509249 |
23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.37218946 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19605981 |
25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.15969329 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 2.11191123 |
27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09087904 |
28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.08432728 |
29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.03250254 |
30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99855989 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92775317 |
32 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90361491 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88440613 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88433121 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87883873 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84350044 |
37 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.77783370 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67458570 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67373140 |
40 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.65382980 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.60186892 |
42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56291303 |
43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52884643 |
44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52413281 |
45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50172152 |
46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49897740 |
47 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49838406 |
48 | MAF_26560356_Chip-Seq_TH1_Human | 1.48482097 |
49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.47882788 |
50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43754451 |
51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35621886 |
52 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33626243 |
53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33481216 |
54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30708934 |
55 | MYC_22102868_ChIP-Seq_BL_Human | 1.26367310 |
56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26291367 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23907554 |
58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23749446 |
59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21547515 |
60 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21517411 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19758140 |
62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18744754 |
63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18084443 |
64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17577804 |
65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14421257 |
66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11654210 |
67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07428590 |
68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06122539 |
69 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04658815 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04323164 |
71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04126748 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03336493 |
73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03085197 |
74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02965211 |
75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01123094 |
76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00799770 |
77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00649672 |
78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97141262 |
79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94650297 |
80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91709093 |
81 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91450203 |
82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90200107 |
83 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89030752 |
84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.88795269 |
85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87998146 |
86 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87919600 |
87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87493396 |
88 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87232750 |
89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.86337690 |
90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85345691 |
91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85345691 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83991040 |
93 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83367370 |
94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82874332 |
95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82652432 |
96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80430842 |
97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79111576 |
98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79053569 |
99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78254565 |
100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76181840 |
101 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.75931295 |
102 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75443419 |
103 | TP53_16413492_ChIP-PET_HCT116_Human | 0.74902039 |
104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74896390 |
105 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.74729964 |
106 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73069922 |
107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72931018 |
108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72931018 |
109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71202189 |
110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.70797418 |
111 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70751936 |
112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70578262 |
113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.70356136 |
114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69724294 |
115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69630811 |
116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.69319641 |
117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69262226 |
118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68234639 |
119 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.67805582 |
120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.67571532 |
121 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.66820995 |
122 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.66312869 |
123 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.66181316 |
124 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.64465493 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.57465046 |
2 | MP0005058_abnormal_lysosome_morphology | 3.17538638 |
3 | MP0003436_decreased_susceptibility_to | 3.12686487 |
4 | MP0002419_abnormal_innate_immunity | 2.99808601 |
5 | MP0003303_peritoneal_inflammation | 2.93747389 |
6 | MP0002148_abnormal_hypersensitivity_rea | 2.83280638 |
7 | MP0005000_abnormal_immune_tolerance | 2.79149825 |
8 | MP0009785_altered_susceptibility_to | 2.71972240 |
9 | MP0002452_abnormal_antigen_presenting | 2.69721888 |
10 | MP0001800_abnormal_humoral_immune | 2.59485315 |
11 | MP0005387_immune_system_phenotype | 2.57132047 |
12 | MP0001790_abnormal_immune_system | 2.57132047 |
13 | MP0003183_abnormal_peptide_metabolism | 2.53232976 |
14 | MP0005025_abnormal_response_to | 2.52506594 |
15 | MP0005671_abnormal_response_to | 2.51688290 |
16 | MP0006082_CNS_inflammation | 2.41673231 |
17 | MP0002723_abnormal_immune_serum | 2.39544919 |
18 | MP0000685_abnormal_immune_system | 2.29956612 |
19 | MP0003300_gastrointestinal_ulcer | 2.28268141 |
20 | MP0002166_altered_tumor_susceptibility | 2.28027449 |
21 | MP0001819_abnormal_immune_cell | 2.26535602 |
22 | MP0002420_abnormal_adaptive_immunity | 2.26334187 |
23 | MP0005464_abnormal_platelet_physiology | 2.06642248 |
24 | MP0002006_tumorigenesis | 2.02452562 |
25 | MP0003724_increased_susceptibility_to | 1.94933158 |
26 | MP0010155_abnormal_intestine_physiology | 1.89648997 |
27 | MP0003172_abnormal_lysosome_physiology | 1.88669083 |
28 | MP0003191_abnormal_cellular_cholesterol | 1.87809272 |
29 | MP0002405_respiratory_system_inflammati | 1.85644435 |
30 | MP0001845_abnormal_inflammatory_respons | 1.82827290 |
31 | MP0000569_abnormal_digit_pigmentation | 1.75588707 |
32 | MP0000716_abnormal_immune_system | 1.70937853 |
33 | MP0001533_abnormal_skeleton_physiology | 1.69398035 |
34 | MP0002396_abnormal_hematopoietic_system | 1.68394707 |
35 | MP0001853_heart_inflammation | 1.67248847 |
36 | MP0002398_abnormal_bone_marrow | 1.65677546 |
37 | MP0005174_abnormal_tail_pigmentation | 1.58833105 |
38 | MP0008004_abnormal_stomach_pH | 1.52817584 |
39 | MP0003656_abnormal_erythrocyte_physiolo | 1.51037961 |
40 | MP0009764_decreased_sensitivity_to | 1.49860393 |
41 | MP0006054_spinal_hemorrhage | 1.49018159 |
42 | MP0000343_altered_response_to | 1.47527929 |
43 | MP0000689_abnormal_spleen_morphology | 1.46890226 |
44 | MP0004883_abnormal_blood_vessel | 1.46781992 |
45 | MP0009333_abnormal_splenocyte_physiolog | 1.45282150 |
46 | MP0008469_abnormal_protein_level | 1.43289861 |
47 | MP0004782_abnormal_surfactant_physiolog | 1.42599848 |
48 | MP0004947_skin_inflammation | 1.42041009 |
49 | MP0005451_abnormal_body_composition | 1.41883874 |
50 | MP0005310_abnormal_salivary_gland | 1.41536360 |
51 | MP0002429_abnormal_blood_cell | 1.40729127 |
52 | MP0001873_stomach_inflammation | 1.40124501 |
53 | MP0000465_gastrointestinal_hemorrhage | 1.37147022 |
54 | MP0002877_abnormal_melanocyte_morpholog | 1.35816213 |
55 | MP0000858_altered_metastatic_potential | 1.34870057 |
56 | MP0002722_abnormal_immune_system | 1.34129184 |
57 | MP0008260_abnormal_autophagy | 1.33809034 |
58 | MP0002138_abnormal_hepatobiliary_system | 1.33260718 |
59 | MP0002277_abnormal_respiratory_mucosa | 1.31237006 |
60 | MP0000490_abnormal_crypts_of | 1.29898248 |
61 | MP0010352_gastrointestinal_tract_polyps | 1.27837032 |
62 | MP0003763_abnormal_thymus_physiology | 1.27353223 |
63 | MP0003075_altered_response_to | 1.22131998 |
64 | MP0004808_abnormal_hematopoietic_stem | 1.22129936 |
65 | MP0001851_eye_inflammation | 1.20154668 |
66 | MP0003448_altered_tumor_morphology | 1.17494354 |
67 | MP0005167_abnormal_blood-brain_barrier | 1.15375099 |
68 | MP0003866_abnormal_defecation | 1.14260889 |
69 | MP0005166_decreased_susceptibility_to | 1.12433219 |
70 | MP0002998_abnormal_bone_remodeling | 1.10389022 |
71 | MP0002332_abnormal_exercise_endurance | 1.10317070 |
72 | MP0009278_abnormal_bone_marrow | 1.06973623 |
73 | MP0001545_abnormal_hematopoietic_system | 1.05544878 |
74 | MP0005397_hematopoietic_system_phenotyp | 1.05544878 |
75 | MP0000604_amyloidosis | 1.04829338 |
76 | MP0000015_abnormal_ear_pigmentation | 1.01627158 |
77 | MP0010307_abnormal_tumor_latency | 0.98047242 |
78 | MP0004264_abnormal_extraembryonic_tissu | 0.96586281 |
79 | MP0003195_calcinosis | 0.95894381 |
80 | MP0002933_joint_inflammation | 0.95576153 |
81 | MP0002009_preneoplasia | 0.94133117 |
82 | MP0002693_abnormal_pancreas_physiology | 0.91808419 |
83 | MP0009765_abnormal_xenobiotic_induced | 0.90658159 |
84 | MP0005257_abnormal_intraocular_pressure | 0.90596861 |
85 | MP0003828_pulmonary_edema | 0.90274423 |
86 | MP0003091_abnormal_cell_migration | 0.90272131 |
87 | MP0002928_abnormal_bile_duct | 0.89025784 |
88 | MP0003795_abnormal_bone_structure | 0.86592696 |
89 | MP0003693_abnormal_embryo_hatching | 0.86139107 |
90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85238736 |
91 | MP0000703_abnormal_thymus_morphology | 0.83867314 |
92 | MP0005390_skeleton_phenotype | 0.83565263 |
93 | MP0005076_abnormal_cell_differentiation | 0.79889877 |
94 | MP0000249_abnormal_blood_vessel | 0.78075925 |
95 | MP0005645_abnormal_hypothalamus_physiol | 0.77842186 |
96 | MP0008007_abnormal_cellular_replicative | 0.77212821 |
97 | MP0000371_diluted_coat_color | 0.77137880 |
98 | MP0009763_increased_sensitivity_to | 0.77131651 |
99 | MP0003045_fibrosis | 0.77003076 |
100 | MP0004510_myositis | 0.76780907 |
101 | MP0001915_intracranial_hemorrhage | 0.71839507 |
102 | MP0002095_abnormal_skin_pigmentation | 0.71178474 |
103 | MP0003566_abnormal_cell_adhesion | 0.70324238 |
104 | MP0005075_abnormal_melanosome_morpholog | 0.67774970 |
105 | MP0001663_abnormal_digestive_system | 0.67575065 |
106 | MP0002019_abnormal_tumor_incidence | 0.65447794 |
107 | MP0003690_abnormal_glial_cell | 0.65214044 |
108 | MP0002136_abnormal_kidney_physiology | 0.65137702 |
109 | MP0005319_abnormal_enzyme/_coenzyme | 0.64388884 |
110 | MP0000767_abnormal_smooth_muscle | 0.64015298 |
111 | MP0001542_abnormal_bone_strength | 0.63220242 |
112 | MP0009840_abnormal_foam_cell | 0.63022601 |
113 | MP0005084_abnormal_gallbladder_morpholo | 0.62673173 |
114 | MP0005164_abnormal_response_to | 0.60811571 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.60215645 |
116 | MP0003806_abnormal_nucleotide_metabolis | 0.58439595 |
117 | MP0002132_abnormal_respiratory_system | 0.57282074 |
118 | MP0005376_homeostasis/metabolism_phenot | 0.54281048 |
119 | MP0004484_altered_response_of | 0.52290872 |
120 | MP0005165_increased_susceptibility_to | 0.51875583 |
121 | MP0001958_emphysema | 0.51703540 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.42181801 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.87891511 |
3 | Eczematoid dermatitis (HP:0000976) | 5.65968448 |
4 | Vacuolated lymphocytes (HP:0001922) | 4.78671089 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.62220172 |
6 | Recurrent viral infections (HP:0004429) | 4.08050236 |
7 | Keratoconjunctivitis sicca (HP:0001097) | 4.06435764 |
8 | Keratoconjunctivitis (HP:0001096) | 3.89076098 |
9 | Abnormality of macrophages (HP:0004311) | 3.81580538 |
10 | Recurrent fungal infections (HP:0002841) | 3.77270090 |
11 | Recurrent skin infections (HP:0001581) | 3.72765809 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 3.69786375 |
13 | Gingivitis (HP:0000230) | 3.56567888 |
14 | Systemic lupus erythematosus (HP:0002725) | 3.52385344 |
15 | Encephalitis (HP:0002383) | 3.42826417 |
16 | Dysostosis multiplex (HP:0000943) | 3.41975709 |
17 | Cellulitis (HP:0100658) | 3.34403956 |
18 | IgM deficiency (HP:0002850) | 3.32131674 |
19 | Increased cerebral lipofuscin (HP:0011813) | 3.28450498 |
20 | Obstructive lung disease (HP:0006536) | 3.25343189 |
21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25343189 |
22 | Hemoptysis (HP:0002105) | 3.22776815 |
23 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.18982990 |
24 | Myositis (HP:0100614) | 3.18400773 |
25 | Periodontitis (HP:0000704) | 3.12846020 |
26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10112606 |
27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10112606 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10112606 |
29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09490312 |
30 | Spontaneous hematomas (HP:0007420) | 3.05129358 |
31 | Gastrointestinal infarctions (HP:0005244) | 3.00899287 |
32 | Meningitis (HP:0001287) | 3.00096841 |
33 | Glomerulonephritis (HP:0000099) | 2.99198478 |
34 | Hematochezia (HP:0002573) | 2.98316035 |
35 | Disinhibition (HP:0000734) | 2.96919870 |
36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.92845812 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.92845812 |
38 | Vasculitis (HP:0002633) | 2.87504332 |
39 | Inflammation of the large intestine (HP:0002037) | 2.82358048 |
40 | Colitis (HP:0002583) | 2.80882204 |
41 | Autoimmune thrombocytopenia (HP:0001973) | 2.80492060 |
42 | Amyloidosis (HP:0011034) | 2.80066929 |
43 | Gangrene (HP:0100758) | 2.78648892 |
44 | Osteomyelitis (HP:0002754) | 2.77728609 |
45 | Recurrent pneumonia (HP:0006532) | 2.77203235 |
46 | Basal ganglia calcification (HP:0002135) | 2.75534596 |
47 | Episodic fever (HP:0001954) | 2.74233509 |
48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69369731 |
49 | Mucopolysacchariduria (HP:0008155) | 2.69369731 |
50 | Gastrointestinal inflammation (HP:0004386) | 2.68609044 |
51 | Loss of speech (HP:0002371) | 2.68032610 |
52 | Thrombocytosis (HP:0001894) | 2.67888320 |
53 | Abnormality of T cell physiology (HP:0011840) | 2.66574588 |
54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64133302 |
55 | Agnosia (HP:0010524) | 2.63654389 |
56 | Interstitial pulmonary disease (HP:0006530) | 2.60154285 |
57 | Chronic otitis media (HP:0000389) | 2.58709470 |
58 | Increased IgM level (HP:0003496) | 2.58502374 |
59 | Chest pain (HP:0100749) | 2.56324766 |
60 | Chronic diarrhea (HP:0002028) | 2.54461355 |
61 | Peritonitis (HP:0002586) | 2.52784708 |
62 | Agammaglobulinemia (HP:0004432) | 2.51563592 |
63 | Anorexia (HP:0002039) | 2.49293154 |
64 | Pustule (HP:0200039) | 2.47276659 |
65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45322647 |
66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45322647 |
67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45322647 |
68 | Orchitis (HP:0100796) | 2.44967022 |
69 | Polyneuropathy (HP:0001271) | 2.42193606 |
70 | Osteolytic defects of the hand bones (HP:0009699) | 2.38750599 |
71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38750599 |
72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.38635946 |
73 | Recurrent bronchitis (HP:0002837) | 2.37299630 |
74 | Abnormality of the pleura (HP:0002103) | 2.36642494 |
75 | Pulmonary embolism (HP:0002204) | 2.35584010 |
76 | Spondylolisthesis (HP:0003302) | 2.33675366 |
77 | Prostate neoplasm (HP:0100787) | 2.31639223 |
78 | Recurrent sinusitis (HP:0011108) | 2.31447194 |
79 | Keratitis (HP:0000491) | 2.29254266 |
80 | Hepatosplenomegaly (HP:0001433) | 2.28990374 |
81 | Poor head control (HP:0002421) | 2.27803600 |
82 | Pulmonary infiltrates (HP:0002113) | 2.24050739 |
83 | Gastrointestinal stroma tumor (HP:0100723) | 2.23001695 |
84 | Leukocytosis (HP:0001974) | 2.21439770 |
85 | Urticaria (HP:0001025) | 2.18201720 |
86 | Eosinophilia (HP:0001880) | 2.17918581 |
87 | Retrobulbar optic neuritis (HP:0100654) | 2.17848496 |
88 | Optic neuritis (HP:0100653) | 2.17848496 |
89 | Vertigo (HP:0002321) | 2.17577556 |
90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15579672 |
91 | Glomerulopathy (HP:0100820) | 2.14264627 |
92 | Abnormality of the endocardium (HP:0004306) | 2.12251219 |
93 | Abnormality of T cells (HP:0002843) | 2.10624988 |
94 | Amaurosis fugax (HP:0100576) | 2.08783931 |
95 | Thyroiditis (HP:0100646) | 2.08058437 |
96 | Hypergammaglobulinemia (HP:0010702) | 2.07773239 |
97 | Autoimmune hemolytic anemia (HP:0001890) | 2.07503156 |
98 | Cheilitis (HP:0100825) | 2.06013042 |
99 | Panhypogammaglobulinemia (HP:0003139) | 2.05716652 |
100 | Axonal loss (HP:0003447) | 2.04612774 |
101 | Abnormality of B cell number (HP:0010975) | 2.03786734 |
102 | Stomatitis (HP:0010280) | 2.03516739 |
103 | Petechiae (HP:0000967) | 2.03233982 |
104 | Stomach cancer (HP:0012126) | 2.01463810 |
105 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00768353 |
106 | Abnormality of the pericardium (HP:0001697) | 1.99283823 |
107 | Sepsis (HP:0100806) | 1.99170387 |
108 | Abnormality of the prostate (HP:0008775) | 1.98045493 |
109 | Increased CSF protein (HP:0002922) | 1.97994326 |
110 | Joint swelling (HP:0001386) | 1.96475315 |
111 | Lymphopenia (HP:0001888) | 1.96038772 |
112 | Granulocytopenia (HP:0001913) | 1.95588612 |
113 | Prolonged bleeding time (HP:0003010) | 1.95450097 |
114 | Arterial thrombosis (HP:0004420) | 1.93339379 |
115 | Nephritis (HP:0000123) | 1.93110822 |
116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91118722 |
117 | Skin ulcer (HP:0200042) | 1.90519146 |
118 | Subacute progressive viral hepatitis (HP:0006572) | 1.89803259 |
119 | Increased density of long bones (HP:0006392) | 1.88963596 |
120 | Nasal polyposis (HP:0100582) | 1.87443866 |
121 | IgA deficiency (HP:0002720) | 1.87272063 |
122 | T lymphocytopenia (HP:0005403) | 1.86981509 |
123 | Abnormality of T cell number (HP:0011839) | 1.86494444 |
124 | Abnormality of eosinophils (HP:0001879) | 1.86179319 |
125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85650747 |
126 | Myocardial infarction (HP:0001658) | 1.85216625 |
127 | Abnormal platelet volume (HP:0011876) | 1.83691861 |
128 | Gingival bleeding (HP:0000225) | 1.83497916 |
129 | Premature loss of primary teeth (HP:0006323) | 1.83310361 |
130 | Thrombophlebitis (HP:0004418) | 1.82483946 |
131 | Epistaxis (HP:0000421) | 1.81091614 |
132 | Viral hepatitis (HP:0006562) | 1.81046227 |
133 | Urethral obstruction (HP:0000796) | 1.80411027 |
134 | B lymphocytopenia (HP:0010976) | 1.79731500 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 3.61755735 |
2 | MAP3K14 | 3.06013475 |
3 | IRAK4 | 2.94741956 |
4 | MAP4K1 | 2.80920009 |
5 | RIPK4 | 2.76903904 |
6 | TGFBR2 | 2.52006920 |
7 | TYK2 | 2.50137437 |
8 | KIT | 2.38867903 |
9 | BMPR2 | 2.35277158 |
10 | TBK1 | 2.24260747 |
11 | IRAK3 | 2.21355799 |
12 | MAPK15 | 2.16876287 |
13 | CSF1R | 2.05869032 |
14 | STK10 | 1.95707986 |
15 | JAK3 | 1.94538180 |
16 | BTK | 1.78843823 |
17 | CSK | 1.78349575 |
18 | TXK | 1.75907250 |
19 | SCYL2 | 1.74192725 |
20 | IKBKB | 1.73580076 |
21 | MAP3K10 | 1.70034195 |
22 | CAMK1D | 1.67525040 |
23 | ZAP70 | 1.66735642 |
24 | FRK | 1.63055061 |
25 | NEK9 | 1.62104133 |
26 | JAK1 | 1.58500940 |
27 | TEC | 1.58465800 |
28 | TAOK3 | 1.52898063 |
29 | ERN1 | 1.51722407 |
30 | FLT3 | 1.51283953 |
31 | MAP3K3 | 1.49465753 |
32 | RPS6KA4 | 1.44834502 |
33 | MATK | 1.43740339 |
34 | IRAK2 | 1.42974571 |
35 | SYK | 1.41665006 |
36 | GRK7 | 1.33985445 |
37 | LYN | 1.31299595 |
38 | YES1 | 1.30346104 |
39 | IKBKE | 1.29213460 |
40 | BMPR1B | 1.29065842 |
41 | MST4 | 1.27934167 |
42 | CLK1 | 1.23251828 |
43 | TRPM7 | 1.19568614 |
44 | EEF2K | 1.18051603 |
45 | CHUK | 1.17788483 |
46 | MOS | 1.17502049 |
47 | MAP2K3 | 1.13759997 |
48 | ITK | 1.12893734 |
49 | LCK | 1.10155544 |
50 | PRPF4B | 1.07482429 |
51 | NUAK1 | 1.01719483 |
52 | HCK | 1.00884280 |
53 | FGFR3 | 0.96235853 |
54 | PIM1 | 0.94104360 |
55 | VRK1 | 0.92353339 |
56 | ACVR1B | 0.91229817 |
57 | HIPK2 | 0.86603604 |
58 | PRKAA2 | 0.81655144 |
59 | JAK2 | 0.80955953 |
60 | MARK3 | 0.80936582 |
61 | PTK6 | 0.79163260 |
62 | LRRK2 | 0.78456365 |
63 | TAOK2 | 0.78367242 |
64 | MAP3K1 | 0.77754371 |
65 | INSRR | 0.76612507 |
66 | MAP3K5 | 0.76497737 |
67 | SIK3 | 0.75844561 |
68 | CDK6 | 0.75692251 |
69 | EIF2AK3 | 0.75636044 |
70 | GRK6 | 0.74795091 |
71 | MAP3K13 | 0.74607324 |
72 | EPHA3 | 0.73786210 |
73 | RIPK1 | 0.73755550 |
74 | ZAK | 0.73379753 |
75 | PIK3CG | 0.73256442 |
76 | CAMKK2 | 0.73242774 |
77 | PDK2 | 0.72736696 |
78 | PTK2B | 0.72363364 |
79 | TAOK1 | 0.71939906 |
80 | MAP3K11 | 0.71224366 |
81 | CAMK1G | 0.71205983 |
82 | MAPKAPK2 | 0.69359057 |
83 | NLK | 0.68086761 |
84 | STK4 | 0.65962008 |
85 | PIM2 | 0.65833645 |
86 | MAP3K6 | 0.65831301 |
87 | STK3 | 0.62658483 |
88 | TESK2 | 0.60862042 |
89 | BRSK2 | 0.58963350 |
90 | FES | 0.58725739 |
91 | TESK1 | 0.58699604 |
92 | STK24 | 0.57924789 |
93 | ADRBK2 | 0.57549978 |
94 | EIF2AK2 | 0.55168943 |
95 | EGFR | 0.54444645 |
96 | MAP3K2 | 0.53804019 |
97 | EPHB1 | 0.53243259 |
98 | MAPK7 | 0.53126554 |
99 | TNK2 | 0.52777508 |
100 | KSR2 | 0.52605984 |
101 | ABL1 | 0.49203248 |
102 | PRKCD | 0.47925921 |
103 | DYRK3 | 0.46926045 |
104 | FGR | 0.46018913 |
105 | PASK | 0.45277051 |
106 | PRKCQ | 0.45047166 |
107 | RPS6KA5 | 0.44947448 |
108 | RPS6KA2 | 0.44763999 |
109 | IRAK1 | 0.44419624 |
110 | PDK1 | 0.44287759 |
111 | RPS6KA6 | 0.43999369 |
112 | KSR1 | 0.43773116 |
113 | ERBB3 | 0.43175559 |
114 | CDK8 | 0.42707140 |
115 | MAPKAPK3 | 0.41985263 |
116 | MAP2K2 | 0.39215927 |
117 | RPS6KL1 | 0.38346834 |
118 | RPS6KC1 | 0.38346834 |
119 | PDGFRB | 0.37103033 |
120 | PAK4 | 0.36523609 |
121 | FYN | 0.31123435 |
122 | TGFBR1 | 0.30919764 |
123 | IGF1R | 0.30907106 |
124 | MAP2K4 | 0.29830543 |
125 | CDK9 | 0.29689998 |
126 | MAP4K2 | 0.29524453 |
127 | INSR | 0.27956563 |
128 | FER | 0.26118584 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.19547646 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.80094504 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49808275 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44226366 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39372934 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.33262543 |
7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.31407447 |
8 | Legionellosis_Homo sapiens_hsa05134 | 2.29387950 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.15051859 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14962317 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11110665 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07261924 |
13 | Lysosome_Homo sapiens_hsa04142 | 2.00469755 |
14 | Tuberculosis_Homo sapiens_hsa05152 | 1.95500370 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84857320 |
16 | Measles_Homo sapiens_hsa05162 | 1.81478626 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80021545 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74782699 |
19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73476394 |
20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70485766 |
21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61150402 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60474438 |
23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56328369 |
24 | Influenza A_Homo sapiens_hsa05164 | 1.55987094 |
25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49129458 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48678332 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46300599 |
28 | Malaria_Homo sapiens_hsa05144 | 1.45874015 |
29 | Salmonella infection_Homo sapiens_hsa05132 | 1.45020881 |
30 | Phagosome_Homo sapiens_hsa04145 | 1.44254016 |
31 | Apoptosis_Homo sapiens_hsa04210 | 1.34419946 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.33021039 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31710332 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.28013322 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24201703 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18888062 |
37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18468221 |
38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14943596 |
39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11078355 |
40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10927424 |
41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09325100 |
42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08667386 |
43 | Allograft rejection_Homo sapiens_hsa05330 | 1.07948830 |
44 | Protein export_Homo sapiens_hsa03060 | 1.07263710 |
45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05871702 |
46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01963076 |
47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99928282 |
48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99060399 |
49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98751752 |
50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.97511627 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96726411 |
52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96593018 |
53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94464006 |
54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92571519 |
55 | Asthma_Homo sapiens_hsa05310 | 0.90680654 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90525753 |
57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88031113 |
58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87545361 |
59 | Hepatitis C_Homo sapiens_hsa05160 | 0.87353824 |
60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85971798 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85839884 |
62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85076711 |
63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84537436 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83027970 |
65 | Platelet activation_Homo sapiens_hsa04611 | 0.82964769 |
66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82319734 |
67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81992053 |
68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78355945 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78156339 |
70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76300525 |
71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69083142 |
72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65046593 |
73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61296119 |
74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60957675 |
75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57754950 |
76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57568123 |
77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57535187 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56269976 |
79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55889225 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.54852898 |
81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52229886 |
82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51426762 |
83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51079914 |
84 | ABC transporters_Homo sapiens_hsa02010 | 0.50722834 |
85 | Bladder cancer_Homo sapiens_hsa05219 | 0.50117891 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49149364 |
87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48467092 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45647144 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.43784164 |
90 | Prostate cancer_Homo sapiens_hsa05215 | 0.43542304 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43197431 |
92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41412958 |
93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40936471 |
94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40337242 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40060429 |
96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39720738 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38781886 |
98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37015448 |
99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36314840 |
100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36227403 |
101 | Homologous recombination_Homo sapiens_hsa03440 | 0.35848972 |
102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35500621 |
103 | Endocytosis_Homo sapiens_hsa04144 | 0.35315971 |
104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34151523 |
105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33936554 |
106 | Adherens junction_Homo sapiens_hsa04520 | 0.33239536 |
107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33042255 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.32395274 |
109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.31696086 |
110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31417013 |
111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31289788 |
112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30805676 |
113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30296311 |
114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24333487 |
115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19371172 |
116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18470548 |
117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.12807276 |
118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.11246667 |